COMBINATION THERAPY FOR THE TREATMENT OR PREVENTION OF CANCER TUMORS

CY1126212T1Undetermined Publication Date: 2026-07-31QBIOTICS PTY LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CY20231100448T
Authority / Receiving Office: CY · CY
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2017-03-23
Filing Date: 2023-08-30
Publication Date: 2026-07-31
Estimated Expiration: 2043-08-30

Application Information

Patent Timeline

23 Mar 2017

Priority

30 Aug 2023

Application

CY20231100448T

31 Jul 2026

Publication

CY1126212T1

IPC: A61K39/00; A61K31/336; A61K45/06

CPC: A61K9/0019; A61K31/336; A61K39/39558; A61P35/00; A61K45/06; C07K16/2818; A61K39/395; A61K39/39

Inventors: REDDELL Paul Warren; CULLEN Jason Kingsley

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

AI Tagging

Technology Topics

Cancer prevention Pharmaceutical drug

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a combination therapy for tumors and comprises the administration of an epoxytigliane compound and an immune checkpoint inhibitor. In certain embodiments, there is a method of treating a tumor and / or treating or preventing one or more concomitant tumors with the therapy. Pharmaceutical compositions and kits containing epoxytigliane compounds and immune checkpoint inhibitors are also described.

Need to check novelty before this filing date? Find Prior Art